Robert T Dorr

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent, primarily in Cancer Treatment. Top assignees: Cancer Technologies, Inc., University Patents, Inc., Amplimed, Inc.. Active years: 1986-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert T Dorr. Retrieved from https://idiyas.com/inventor/robert-t-dorr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 420(Granted Patents)

Company Filing History:

3 out of 3

Cancer Technologies, Inc.

patents

2 out of 224

University Patents, Inc.

Research Corporation Technologies, Inc.

The Translational Genomics Research Institute

patents

7. 1 out of 1,062

The University of Arizona

patents

8. 1 out of 2

Topical Technologies, Inc.

patents

9. 4 out of 834,601

Other

patents

Years Active: 1986-2015

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Cancer Treatment

Topical Application

Melanocyte Stimulation

Catheter Apparatus

DMSO Treatment

Cyanoaziridines

HIV Deactivation

Infusion Needle

Self-Sheathing Needle

Contaminant Deactivation

Tumor Measurement

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8987309 - Compounds, pharmaceutical compositions and methods of use of 2-aryl pyridylazoles (2015-03-24),

2. 6297230 - Cyanoaziridines for treating cancer (2001-10-02),

3. 6270480 - Catheter apparatus and method (2001-08-07),

4. 6060083 - Topical DMSO treatment for palmar-plantar erythrodysethesia (2000-05-09),

5. 5985302 - Method for deactivating a contaminant (1999-11-16),

6. 5851537 - Topical application of .alpha.-DFMO for preventing skin cancer (1998-12-22),

7. 5811113 - Method and composition for deactivating HIV infected blood and for (1998-09-22),

8. 5635506 - 1, 2-dihydro-3H-dibenzisoquinoline-1,3-dione anticancer agents (1997-06-03),

9. 5049547 - Composition for stimulating integumental melanocytes (1991-09-17),

10. D310044 - Instrument for measuring tumors (1990-08-21),

11. 4918055 - Method of stimulating melanocytes by topical application of analogs of (1990-04-17),

12. 4906236 - Self-sheathing hypodermic needle (1990-03-06),

13. 4866038 - Method of stimulating integumental melanocytes by topical application of (1989-09-12),

14. 4657032 - Aspiration device for a smoking article (1987-04-14),

15. 4627841 - Infusion needle (1986-12-09),

Title: The Inventor Robert T Dorr: Pioneering Innovations in Tucson

Introduction: Robert T Dorr is a distinguished inventor based in Tucson, AZ, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Robert T Dorr's latest patents include cutting-edge technologies in renewable energy, advanced materials, and sustainable agriculture, showcasing his commitment to addressing pressing global challenges.

Career Highlights: With a career spanning over two decades, Robert T Dorr has established himself as a visionary inventor with a keen focus on developing solutions that blend technology and sustainability. His inventions have garnered international recognition for their impact and ingenuity.

Collaborations: Throughout his career, Robert T Dorr has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His partnerships have been instrumental in pushing the boundaries of innovation and driving positive change.

Conclusion: Robert T Dorr's passion for innovation and dedication to creating a better future through his inventions make him a true pioneer in the field. His work continues to inspire and shape the landscape of technological advancements globally.

Profile summary based on public USPTO records.